Assembly Biosciences (ASMB) Enterprise Value (2010 - 2026)
Assembly Biosciences (ASMB) posted quarterly Enterprise Value of -$226.6 million for Q1 2026, down 148.94% year-over-year from $463.1 million in Q1 2025, and up 8.67% quarter-over-quarter from -$248.1 million in Q4 2025.
Assembly Biosciences (ASMB) Enterprise Value (2010 - 2026) Analysis & Trends
Assembly Biosciences' Enterprise Value history runs 17 years deep, the most recent figure standing at -$226.6 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 148.94% year-over-year to -$226.6 million; the TTM figure through Mar 2026 stood at -$226.6 million (down 148.94% YoY), while the FY2025 annual figure was -$248.1 million, down 121.37% from the prior year.
- Enterprise Value for Q1 2026 stood at -$226.6 million, up from -$248.1 million in the prior quarter.
- The five-year high for Enterprise Value was -$46.2 million in Q3 2023, with the low at -$248.1 million in Q4 2025.
- The 5-year median for Enterprise Value is -$109.2 million (2024), against an average of -$120.7 million.
- The sharpest annual moves came in 2023 and 2026: Enterprise Value jumped 57.47% in 2023, then tumbled 148.94% in 2026.
- Assembly Biosciences' Enterprise Value stood at -$91.6 million in 2022, then plunged by 42.18% to -$130.2 million in 2023, then climbed by 13.95% to -$112.1 million in 2024, then tumbled by 121.37% to -$248.1 million in 2025, then climbed by 8.67% to -$226.6 million in 2026.
- Business Quant data shows ASMB's Enterprise Value at -$226.6 million in Q1 2026, -$248.1 million in Q4 2025, and -$232.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | -320.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -320.36 Mn |
| Mar 31, 2026 | -226.60 Mn |
| Dec 31, 2025 | -248.11 Mn |
| Sep 30, 2025 | -232.56 Mn |
| Jun 30, 2025 | -74.98 Mn |
| Mar 31, 2025 | -91.03 Mn |
| Dec 31, 2024 | -112.08 Mn |
| Sep 30, 2024 | -94.95 Mn |
| Jun 30, 2024 | -109.22 Mn |
| Mar 31, 2024 | -112.34 Mn |
| Dec 31, 2023 | -130.25 Mn |
| Sep 30, 2023 | -46.21 Mn |
| Jun 30, 2023 | -59.83 Mn |
| Mar 31, 2023 | -73.02 Mn |
| Dec 31, 2022 | -91.61 Mn |
| Sep 30, 2022 | -108.65 Mn |
| Jun 30, 2022 | -116.69 Mn |
| Mar 31, 2022 | -123.00 Mn |
| Dec 31, 2021 | -146.63 Mn |
| Sep 30, 2021 | -180.90 Mn |